Drug Shortage Report for MYLAN-LATANOPROST/TIMOLOL

Last updated on 2025-04-23 History
Report ID 251255
Drug Identification Number 02373068
Brand name MYLAN-LATANOPROST/TIMOLOL
Common or Proper name LATANOPROST/TIMOLOL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LATANOPROST TIMOLOL
Strength(s) 50MCG 5MG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 1
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-04-02
Actual start date 2025-04-08
Estimated end date 2025-04-24
Actual end date 2025-04-17
Shortage status Resolved
Updated date 2025-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-04-23 French Compare
v15 2025-04-23 English Compare
v14 2025-04-14 French Compare
v13 2025-04-14 French Compare
v12 2025-04-14 English Compare
v11 2025-04-09 French Compare
v10 2025-04-09 English Compare
v9 2025-04-03 English Compare
v8 2025-03-26 French Compare
v7 2025-03-26 English Compare
v6 2025-03-10 French Compare
v5 2025-03-10 English Compare
v4 2025-03-03 French Compare
v3 2025-03-03 English Compare
v2 2025-02-26 French Compare
v1 2025-02-26 English Compare

Showing 1 to 16 of 16